What is VBIO's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for VBIO?

P/E (TTM) is n/a and 52-week range is $1.44 to $32.50 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s VBIO figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for VBIO?

The company profile lists revenue (TTM) near $2M, net income (TTM) near $-2.36B, EPS (TTM) near $-8.23 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Valion Bio Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in San Antonio, Texas, US, 4.2M shares outstanding, ISIN US8887053085 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Free AI scores & summaries library

Valion Bio Inc

$VBIO

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$1.20

-2.44%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in San Antonio, Texas and currently employs 52 full-time employees. The company went IPO on 2021-11-11. The firm offers Entolimod, which is a drug used to treat acute radiation syndrome (ARS). Entolimod is a toll-like receptor 5 (TLR5) agonist that activates an innate immune pathway to prevent cell death in the bone marrow and epithelial tissues across systems impacted by radiation and age. Its pipeline also includes Entolimod to treat neutropenia and lymphocyte exhaustion, as well as Entolasta, an immunologically optimized variant of Entolimod for chronic applications. Its subsidiary, Velocity Bioworks, is a full-service contract development and manufacturing organization (CDMO) that is based in San Antonio, Texas. The company offers upstream and downstream process development and optimization; analytical testing, assay development, and qualification; quality control and stability testing; microbial and mammalian expression systems; technology transfer and program management services.

Employees

Website

tivichealth.com

IPO

2021-11-11

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)